Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065221

SVP & Chief Commercial Officer sold 6,061 shares at $13.16 ($79,763)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NORTHCOTT JOHN SVP & Chief Commercial Officer 2021-11-16 Sale −6,061 $13.16 $79,763 194,854 D: show line 1 in the form
Open-market sales · 6,061 sh · avg $13.16 · $79,763
Loading xslF345X03/doc4.xml…